Summary.-The presence of antibody in patients with malignant melanoma is well established if one examines the serum. In this report we have attempted to identify antibody within solid tumours showing that they are rarely present in any appreciable quantity on the surface of tumour cells but can be seen frequently on a number of different types of host cell within the tumours. This is discussed in the light of the role of antibody in the circulation and the possibility of antibody behaving as a blocking factor in vivo. ANTI-TUMOUR antibodies have been re-ported in the serum of patients with a wide variety of malignancies (Nairn, 1974; Mastrangelo, Laucius and Outzen, 1974). A definitive role, however, has not been estab-lished for such antib...
The sera from 34 patients with malignant melanoma at various clinical stages of the disease were exa...
thesisAntibodies to tumor antigens have been detected by several means including complement fixation...
The distribution of a recently produced melanoma specific antibody (HMB-45) has been evaluated histo...
SUMMARY-Two antibody/antigen reactions, previously described in human malignant melanoma, were studi...
Anti-immunoglobulin antibodies, previously shown to occur in a number of diseases, have been identif...
Summary.-Previous studies, using plasmapheresis to remove blocking factors of cell-mediated cytotoxi...
Malignant melanomas, although less common than most malignancies, account for 1% of all cancers, and...
A case of cutaneous malignant melanoma metastatic to regional lymph nodes is presented. Blastoid tra...
Immunoglobulin G (IgG) antibodies reactive with intracellular components of transformed cells were d...
Six monoclonal antibodies(Mabs) including 4 anti-melanoma, one anti-glioma, and one anti-HLA-DR have...
I.F. 0.882 Abstract: Sera from 46 patients with malignant melanoma (MM) in different clinical stage...
SUMMARY-Indirect immunofluorescent (IF) tests were done on acetone-fixed imprints of 10 malignant me...
Human monoclonal antibodies were generated by fusing a nonsecretory variant of murine mycloma cells ...
The low titer and incidence of autologous antibody to melanoma has hampered its evaluation. Through ...
Malignant melanoma is an immunogenic tumour capable of inducing a humoral immune response, as shown ...
The sera from 34 patients with malignant melanoma at various clinical stages of the disease were exa...
thesisAntibodies to tumor antigens have been detected by several means including complement fixation...
The distribution of a recently produced melanoma specific antibody (HMB-45) has been evaluated histo...
SUMMARY-Two antibody/antigen reactions, previously described in human malignant melanoma, were studi...
Anti-immunoglobulin antibodies, previously shown to occur in a number of diseases, have been identif...
Summary.-Previous studies, using plasmapheresis to remove blocking factors of cell-mediated cytotoxi...
Malignant melanomas, although less common than most malignancies, account for 1% of all cancers, and...
A case of cutaneous malignant melanoma metastatic to regional lymph nodes is presented. Blastoid tra...
Immunoglobulin G (IgG) antibodies reactive with intracellular components of transformed cells were d...
Six monoclonal antibodies(Mabs) including 4 anti-melanoma, one anti-glioma, and one anti-HLA-DR have...
I.F. 0.882 Abstract: Sera from 46 patients with malignant melanoma (MM) in different clinical stage...
SUMMARY-Indirect immunofluorescent (IF) tests were done on acetone-fixed imprints of 10 malignant me...
Human monoclonal antibodies were generated by fusing a nonsecretory variant of murine mycloma cells ...
The low titer and incidence of autologous antibody to melanoma has hampered its evaluation. Through ...
Malignant melanoma is an immunogenic tumour capable of inducing a humoral immune response, as shown ...
The sera from 34 patients with malignant melanoma at various clinical stages of the disease were exa...
thesisAntibodies to tumor antigens have been detected by several means including complement fixation...
The distribution of a recently produced melanoma specific antibody (HMB-45) has been evaluated histo...